- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06258954
Effect of 3D-printed Reconstruction System in Size of Left DLT
February 5, 2024 updated by: Yihao Zhu, Sichuan Cancer Hospital and Research Institute
Effect of 3D-printed Reconstruction Automated Matching System in Selecting the Size of Left Double-lumen Tube
The precise and accurate size of DLT is a prerequisite to ensure its accurate position of its placement.
Three-dimensional (3D) reconstruction technology can accurately reproduce the tracheobronchial structure to improve the correct size selection of DLT.
To make it simpler, the investigators developed an automatic comparison software for 3D reconstruction based on computed tomography data (3DRACS).
In this study, the investigators aimed to prove that 3DRACS is much more efficient in endobronchial intubation compared to the traditional method.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Lung isolation techniques are commonly used to facilitate surgical exposure and to provide single-lung ventilation for patients undergoing various intra-thoracic procedures.
Lung isolation is primarily accomplished with a double-lumen tube (DLT) or bronchial blocker.
One published study showed that residents with limited experience had a 40% error rate in accurately placing a DLT.
The accurate choice of the size of DLT is a prerequisite for good lung isolation.Currently,
There is lack of proper objective criteria for selecting size of DLT.
DLT size selection is estimated empirically using the patient's height and sex, and studies have shown that the size of DLT according CT images of the chest is more accurate than experience.
The investigators have developed an automatic comparison software for 3D reconstruction based on CT data (3DRACS).
It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size of the DLT for lung isolation.
The aim of this study was to compare whether the use of 3DRACS to select a DLT size compared to conventional empirical selection methods could improve incidence of DLT intubation success and reduce airway injury.
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xin Wang, master
- Phone Number: +8685420443
- Email: 675202449@qq.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged between 18 and 75 years.
- American Society of Anesthesiologists Physical Status (ASA-PS) I-III.
- Planned to receive lung resection surgery during lung isolation techniques by using DLT.
- Signed informed written consent.
Exclusion Criteria:
The participant experiences any of the following:
- Spinal malformation,
- Expected difficult airway
- Tracheal stenosis
- Tracheal tumor
- Bronchial tumor
- Distorted airway anatomy
- Tumors of the mouth or neck
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 3D group
Using automatic comparison software for 3D reconstruction to determine the size of DLT.
|
3D reconstruction based on CT data and It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size of the DLT for lung isolation.
|
|
Placebo Comparator: control group
The size of DLT is based on patient's sex and height.
|
In control group, the size of DLT is based on patient's sex and height.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the success rates of placement of left DLT without FOB
Time Frame: After intubation,an average of 2 hours
|
Conventional blindly endobronchial intubation is performed firstly and clinical verification was made by the same anesthesiologist, followed by the supervising anesthesiologist using a FOB to check DLT position and successful intubation was considered if the position was proper.
|
After intubation,an average of 2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The time of completing the left DLT's position
Time Frame: After intubation,an average of 2 hours
|
There are two different situations that we need to describe.
First, it starts from the cuff of left DLT crosses the vocal cords, and stops when the left DLT position succeeds without FOB(attempts≤3).
A stopwatch is used for this purpose, where it is ON when the cuff of left DLT crosses the vocal cords and stops when intubating anesthesiologist considers the left DLT is correctly positioned.
Second, it starts from the cuff of left DLT crosses the vocal cords and stops when positioning successfully with FOB after three attempts all fail.
Each attempt is defined as returning the bronchial lumen of the left DLT to the trachea and then attempting to reinsert it.
|
After intubation,an average of 2 hours
|
|
The number of the patients who need to change the size of the left DLT
Time Frame: After intubation,an average of 2 hours
|
If the position of the left DLT under the FOB guidance doesn't match and the intubation fails because of the improper size of the left DLT, we need to change another left DLT.
|
After intubation,an average of 2 hours
|
|
Appropriate standard for the left DLT
Time Frame: After intubation,an average of 2 hours
|
Objective criteria is injecting air into the cuff.
When the pressure inside the left DLT is 25 mmHg, it will be stopped and connected to the anesthesia machine.
And the air leakage phenomenon is adjusted when the peak pressure is lower than 30 cm H2O.
Oversized left DLT is defined that good pulmonary isolation could be achieved by injecting <1 ml of air into the bronchial cuff and <2 ml of air into the main tracheal cuff, while more than 3 or 6 ml of air into the two cuff is defined undersized left DLT.
|
After intubation,an average of 2 hours
|
|
Lung collapse
Time Frame: At 10 and 20 minute after pleurotomy
|
Ten and 20 min after pleurotomy, the degree of pulmonary atrophy is assessed by a chest surgeon unaware of the grouping with an eleven-point Likert scale with 0 marked as no pulmonary atrophy at all and 10 as most perfect lung collapse.
|
At 10 and 20 minute after pleurotomy
|
|
Grading of the airway injury
Time Frame: After extubation,an average of 1 hours
|
it will be done by a trained anesthesiologist with over 10 years of FOB experience, The severity of the tracheal injury is defined as mild (redness, edema, one to three speckled hemorrhagic lesions), moderate (over 3 mild lesions or one diffuse hemorrhagic lesion), and severe (more than 2 diffuse hemorrhagic lesions) The type of lesions in vocal cords is classified into edema with inflamed mucosa, petechiae (small red spots on the mucosa), and hematoma (bleeding into the mucosa).
|
After extubation,an average of 1 hours
|
|
Postoperative sore throat and hoarseness
Time Frame: 1, 2 days after surgery
|
they are defined as persistent resting pain in the throat region, where throat pain scores are assessed using VAS score i.e., 0 for no pain, and 10 for unbearable pain, while hoarseness is defined as a change in the quality of voice observed by the patient.
|
1, 2 days after surgery
|
|
Oxygenation during one-lung ventilation
Time Frame: At the end of surgery.
|
it is defined as the area under the curve of the SpO2/FiO2 ratio during OLV.
The SpO2 and FiO2 values are automatically collected by the monitor at 30-second intervals and any abnormal data due to equipment or human error is replaced with the previous correct data.
|
At the end of surgery.
|
|
Times of using FOB
Time Frame: At the end of surgery.
|
The times of using FOB guiding to place the left DLT correctly after three attempts all fail.
|
At the end of surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yihao Zhu, master, department of anesthesiology, sichuan cancer hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2024
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
July 30, 2024
Study Registration Dates
First Submitted
January 28, 2024
First Submitted That Met QC Criteria
February 5, 2024
First Posted (Actual)
February 14, 2024
Study Record Updates
Last Update Posted (Actual)
February 14, 2024
Last Update Submitted That Met QC Criteria
February 5, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- scchec-20240128
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data are available on reasonable request.
The raw data are available from the corresponding author with applicable reason after publishing findings to a peer-reviewed journal.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer of Lung
-
Third Military Medical UniversityRecruitingMediastinal Metastases of Lung CancerChina
-
Mayo ClinicMedtronic - MITGTerminatedLung Neoplasms | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | Metastatic Cancer to the LungUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); United States Department of Defense; National...RecruitingLung Cancer | Cancer of ThoraxUnited States
-
National Cancer Institute (NCI)CompletedSquamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer | Stage IB Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
-
Galvanize Therapeutics, Inc.TerminatedCancer of Lung, Kidney or LiverHong Kong, Spain, Netherlands
-
Jerod L Stapleton, PhDNational Cancer Institute (NCI); University of Louisville; G02 for Lung CancerRecruitingLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer, Lung | Cancer of the Lung | Pulmonary Neoplasm | Lung Cancers | Neoplasm, Pulmonary | Cancers, Lung | Cancer, Pulmonary | Cancers, Pulmonary | Pulmonary CancersUnited States
-
National Cancer Institute (NCI)National Center for Complementary and Integrative Health (NCCIH); Radiation...CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
Clinical Trials on 3D reconstruction
-
Ruijin HospitalGuangdong Provincial People's Hospital; Union hospital of Fujian Medical UniversityCompleted
-
Medical University of GrazNot yet recruitingLiver Cancer | Liver Surgery | Liver | 3D-reconstruction | Volumetric Analysis | Surgical PlanningAustria
-
University Hospital, Basel, SwitzerlandActive, not recruitingTotal Knee Arthroplasty (TKA)Switzerland
-
Guangdong Provincial People's HospitalActive, not recruiting
-
Yonsei UniversityCompletedGastric CancerKorea, Republic of
-
Mayo ClinicCompletedRegenerative Medicine | Nasal Surgical ProceduresUnited States
-
University of PecsCompleted
-
Fundació d'investigació Sanitària de les Illes...Asociacion Española de ColoproctologiaNot yet recruitingColon Neoplasms | Locally Advanced Colon Cancer | 3D Reconstruction
-
Imperial College LondonRecruitingObesity | Bariatric Surgery Candidate | Body Image DisorderUnited Kingdom